Stop rejections before they reach the payer. The Claims Scrubber validates frequency, quantity, bundling logic, and primary diagnosis positioning across entire claim files before submission.
Even clinically correct encounters are rejected due to frequency violations, excessive quantities, unbundled panels, or incorrect primary diagnosis sequencing. Payers apply complex submission-level logic that most internal systems do not replicate.
Screens batches and XML files before they leave your environment, catching submission-level logic that internal systems miss.
Applies the same complex frequency, quantity, and bundling rules that payers use to adjudicate claims.
Every claim file is validated for structural accuracy and compliance before it reaches the clearinghouse.
Validates full claim files for structural accuracy and compliance before submission.
Detects maximum-per-day violations and excessive service units that commonly trigger denials.
Prevents secondary codes from being incorrectly positioned as primary diagnoses in submission files.
Identifies unbundled laboratory panels, E/M conflicts, and procedural redundancies prior to payer edits.
First-Pass Rate
AR Aging
Faster Cash Cycles
Denial Repeats
Improve first-pass acceptance rates, reduce AR aging, and accelerate cash realization.
Deliver cleaner submissions, reduce repeat denial cycles, and standardize compliance enforcement across facilities.
Shares are usually issued within two weeks of completing your investment. You’ll get your EIS3 certificate 2–4 months later, once HMRC processes it. This is what you’ll need to claim your tax relief.
You must hold your shares for at least three years from the date they were issued (or when the company started trading, whichever is later). Selling early could mean losing your tax relief.
You may exit if the company is acquired, lists on a stock exchange, or arranges a buyback or sale to other investors. Most exits happen after three years to keep the EIS tax benefits.
We’ll send regular updates—usually every quarter or six months—about company progress. You can also contact us anytime. We believe in open, transparent communication with our investors.
As with all early-stage investments, there’s a risk of losing money. But EIS helps reduce that risk:
✔️ 30% income tax relief
✔️ Loss relief if things don’t work out
✔️ Tax-free growth on exit
Jump Right In
Skip the Demo, Sign Up Instantly!
Take a Tour: HealthOrbit AI Scribe in Action
Talk to Our Customer Success Experts
